Cargando…

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

The implementation and access to combined antiretroviral treatment (cART) have dramatically improved the quality of life of people living with HIV (PLWH). However, some comorbidities, such as neurological disorders associated with HIV infection still represent a serious clinical challenge. Soluble f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duran-Castells, Clara, Llano, Anuska, Kawana-Tachikawa, Ai, Prats, Anna, Martinez-Zalacain, Ignacio, Kobayashi-Ishihara, Mie, Oriol-Tordera, Bruna, Peña, Ruth, Gálvez, Cristina, Silva-Arrieta, Sandra, Clotet, Bonaventura, Riveira-Muñoz, Eva, Ballana, Esther, Prado, Julia G., Martinez-Picado, Javier, Sanchez, Jorge, Mothe, Beatriz, Hartigan-O’Connor, Dennis, Wyss-Coray, Tony, Meyerhans, Andreas, Gisslén, Magnus, Price, Richard W., Soriano-Mas, Carles, Muñoz-Moreno, José Antonio, Brander, Christian, Ruiz-Riol, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Virus-Cell Interactions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972991/ https://www.ncbi.nlm.nih.gov/pubmed/36719240 http://dx.doi.org/10.1128/jvi.01655-22

Ejemplares similares

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
por: Duran-Castells, Clara, et al.
Publicado: (2023)

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
por: Oriol-Tordera, Bruna, et al.
Publicado: (2020)

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
por: Ezeonwumelu, Ifeanyi Jude, et al.
Publicado: (2022)

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
por: Ruiz-Riol, M., et al.
Publicado: (2017)

Virological, Immune and Host genetics Markers in the Control of HIV Infection
por: Mothe, Beatriz, et al.
Publicado: (2009)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
por: Llano, Anuska, et al.
Publicado: (2013)

Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
por: Kawana-Tachikawa, Ai, et al.
Publicado: (2014)

Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
por: Olvera, Alex, et al.
Publicado: (2021)

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
por: Badia, Roger, et al.
Publicado: (2018)

Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro
por: Olvera, Alex, et al.
Publicado: (2018)

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
por: Oriol-Tordera, Bruna, et al.
Publicado: (2022)

Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections
por: Romero-Martín, Luis, et al.
Publicado: (2022)

Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection
por: Ezeonwumelu, Ifeanyi Jude, et al.
Publicado: (2022)

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells
por: Badia, Roger, et al.
Publicado: (2016)

Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1
por: Riveira-Muñoz, Eva, et al.
Publicado: (2023)

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers
por: Rosás-Umbert, Miriam, et al.
Publicado: (2019)

CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control
por: Mothe, Beatriz, et al.
Publicado: (2012)

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection
por: Prats, Anna, et al.
Publicado: (2021)

In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial
por: Rosás-Umbert, Miriam, et al.
Publicado: (2020)

Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
por: Borgognone, Alessandra, et al.
Publicado: (2022)

The Genome-wide Methylation Profile of CD4(+) T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression
por: Moron-Lopez, Sara, et al.
Publicado: (2020)

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2023)

Small steps forward for HIV vaccine development
por: Mothe, Beatriz, et al.
Publicado: (2020)

Novel Nested Peptide Epitopes Recognized by CD4(+) T Cells Induced by HIV-1 Conserved-Region Vaccines
por: Borthwick, Nicola, et al.
Publicado: (2020)

A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
por: Mothe, Beatriz, et al.
Publicado: (2015)

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
por: Mothe, Beatriz, et al.
Publicado: (2020)

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages
por: Pujantell, Maria, et al.
Publicado: (2017)

Homeostatically Maintained Resting Naive CD4(+) T Cells Resist Latent HIV Reactivation
por: Tsunetsugu-Yokota, Yasuko, et al.
Publicado: (2016)

Definition of the viral targets of protective HIV-1-specific T cell responses
por: Mothe, Beatriz, et al.
Publicado: (2011)

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy
por: Gálvez, Cristina, et al.
Publicado: (2021)

Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
por: Castellví, Marc, et al.
Publicado: (2020)

HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design
por: Bayón-Gil, Ángel, et al.
Publicado: (2020)

T-Follicular-Like CD8(+) T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG
por: Romero-Martín, Luis, et al.
Publicado: (2022)

Altered T‐cell subset distribution in the viral reservoir in HIV‐1‐infected individuals with extremely low proviral DNA (LoViReTs)
por: Gálvez, Cristina, et al.
Publicado: (2022)

Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2014)

P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome
por: Mothe, B, et al.
Publicado: (2009)

Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells
por: Ruiz, Alba, et al.
Publicado: (2019)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
por: Puigdomènech, Isabel, et al.
Publicado: (2008)

Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
por: Castellví, Marc, et al.
Publicado: (2020)

Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller
por: Pernas, María, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_id1mrh210918q568nil5980gi3